A nomogram integrating the clinical and CT imaging characteristics for assessing spread through air spaces in clinical stage IA lung adenocarcinoma
Yantao Yang(Kunming Medical University), Lianhua Ye(Kunming Medical University), Wangcai Li(Kunming Medical University), Li Li(Peking University), Chen Zhou(Jiangnan University), Jia Luo(Kunming Medical University), Yunchao Huang(North China University of Water Resources and Electric Power), Jie Zhao(Kunming Medical University), Jiezhi Jiang(Kunming Medical University), Zhenghong Yang(Kunming Medical University), Guangqiang Zhao(Kunming Medical University), Huilian Hu(Qujing Normal University), Yaowu Duan(Kunming Medical University), Qiubo Huang
Cited by 3
Related Papers
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey
|Lung Cancer|2018|134